The largest database of trusted experimental protocols

6 protocols using pgl3 basic

1

Analyzing Cellular Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
All information regarding antibodies used in this study is provided in Table S7. Rapamycin (Rapa), everolimus (RAD001), deferoxamine (DFX), DAPT and MHY1485 were purchased from Selleck Chemicals (Houston, TX, USA). Jagged1-Fc was obtained from R&D system (Minneapolis, MN, USA). Lipofectamine RNAiMax was obtained from Invitrogen (Carlsbad, CA, USA). pRL-TK, pGL3-Basic, pcDNA3.0, pcDNA3.0-HA-HIF-1α, lenti-CRISPRv2 plasmids and packaging vectors (pVSVG and psPAX2) were purchased from Addgene (Cambridge, MA, USA).
+ Open protocol
+ Expand
2

Luciferase Reporter Assay for HOXC13 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA fragments containing wild-type (WT) or mutant sequences for HOXC13 binding were synthesized and cloned into luciferase reporter vectors (pGL3-Basic; Addgene, Inc.). DNMT3A wild-type or mutant plasmids and Oe-HOXC13 or Oe-NC were co-transfected into cells using Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.) for 48 h, according to the manufacturer's protocol. Transfected cells (1x105 per well) were seeded into 96-well plates and luciferase activity was determined 48 h after transfection using Dual-Luciferase® Reporter (DLR™) Assay System (Promega Corporation), according to the manufacturer's instructions. Firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Plasmid Transfection and Knockdown Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmids used in this study, such as SBE4, TOP, FOP, pGL3‐basic, pGL3‐promoter, and pRL‐TK, were purchased from Addgene and Promega and preserved in our laboratory. The pGL3‐basic, pGL3‐promoter, and pRL‐TK plasmids were used for the dual‐luciferase reporter assay. The gDNA of KYSE150 cells was used as the template for amplification of the DNA fragments of target genes that were obtained from ChIP‐seq. The primers used for the PCR reaction are listed in Table S1. TransIntro™ EL Transfection Reagent (TransGen Biotech) was used for the transfection of plasmids. Small interfering RNAs (RiboBio) were used to knock down Smad7. The Smad7 siRNA sequences are 5′‐GGTAGTTCCGAAAGCTGAT‐3′ (Smad7‐siRNA1) and 5′‐ CCTATAGAAGATACTAGAT‐3′ (Smad7‐siRNA2). The riboFECT CP Transfection Kit (RiboBio) was used for the transfection of siRNA.
+ Open protocol
+ Expand
4

Characterizing c-Myc Binding in TMEM14A Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Potential binding sites for c-Myc in the TMEM14A promoter were predicted using GeneCards database (www.genecards.org). According to the predictions, DNA fragments containing wild-type (WT) or mutant sequences for c-Myc binding were synthesized and cloned into luciferase reporter vectors (pGL3-Basic; Addgene, Inc.). These constructs (namely, WT and Mut promoter), were introduced with an internal reporter plasmid and oec-Myc into human CAOV3 cells by using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) for 48 h and luciferase activities were measured 48 h after transfection using a dual-luciferase reporter gene kit (Beijing Yuanpinghao Biotechnology Co., Ltd.). Firefly luciferase activity was normalized to Renilla luciferase activity. Relative Firefly and Renilla luciferase activities were measured using the Dual-Luciferase Reporter Gene Assay kit (Promega Corporation).
+ Open protocol
+ Expand
5

NKAP Regulation by miR-24-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
A luciferase reporter assay was performed as described previously [25 (link)]. Briefly, the luciferase reporter vector pGL3-basic (Addgene) was used to generate a luciferase reporter construct. Wildtype and mutant NKAP fragments containing the KpnI and XhoI restriction enzyme cutting sequences were synthesized. The synthesized DNA was digested with KpnI and XhoI, followed by insertion into the pGL3-basic vector. Next, hypoxic HUVECs were seeded at a density of 1×106 cells/well in six-well plates. Then, hypoxic HUVECs were cotransfected with pGL3-NKAP-WT and miR-24-3p or pGL3-NKAP-MUT and miR-24-3p. The cells were maintained in an incubator for 24 h. Finally, relative luciferase activity was determined by a dual luciferase assay (Promega, U.S.A.).
+ Open protocol
+ Expand
6

Evaluating ESR1-LBD Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 24-well plate (2 × 105 cells/well) 1 day before transfection and treatments were added accordingly to the experimental design (not treated, vehicle/DMSO 0.01% or fulvestrant 1 µM). For the putative promoter experiment, three different human genomic DNA regions representing putative ESR1-LBD promoter (pESR1-LBD-1/2/3) were cloned into pGL3.basic plasmid (Promega, USA; Supplementary Data 7). BC cells were co-transfected with pGL3.basic (NC) or p-ESR1-LBD reporter plasmids (750 ng) and pRL-TK Renilla Luciferase plasmid (75 ng) (Addgene, USA) by using Lipofectamine 2000 (Invitrogen, USA) and following reagent protocol. For ERα-driven transcriptional activity experiment, BC cells were co-transfected with 3x-ERE-TATA-Luciferase reporter plasmid (750 ng) and pRL-TK Renilla Luciferase plasmid (75 ng) (Addgene, USA) by using the same procedure described above. Cells were harvested 24 h after transfection and cell lysates were used for Dual-Luciferase® Reporter Assay System analysis, according to the manufacturer’s instructions (Promega, USA). Luciferase bioluminescence measurements were performed with the Veritas™ Microplate Luminometer (Promega, USA). For each sample, Firefly luciferase activity was normalized against Renilla luciferase activity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!